Eagle Pharmaceuticals, Inc. (EGRX): Price and Financial Metrics

EGRX POWR Grades

• Value is the dimension where EGRX ranks best; there it ranks ahead of 99.75% of US stocks.
• EGRX's strongest trending metric is Quality; it's been moving down over the last 178 days.
• EGRX's current lowest rank is in the Momentum metric (where it is better than 4.74% of US stocks).

EGRX Stock Summary

• With a year-over-year growth in debt of 123.33%, EAGLE PHARMACEUTICALS INC's debt growth rate surpasses 89.62% of about US stocks.
• In terms of twelve month growth in earnings before interest and taxes, EAGLE PHARMACEUTICALS INC is reporting a growth rate of 612.89%; that's higher than 97.14% of US stocks.
• As for revenue growth, note that EGRX's revenue has grown 66.48% over the past 12 months; that beats the revenue growth of 88.7% of US companies in our set.
• Stocks that are quantitatively similar to EGRX, based on their financial statements, market capitalization, and price volatility, are GLBE, WEAV, RCEL, FLYW, and VBIV.
• Visit EGRX's SEC page to see the company's official filings. To visit the company's web site, go to www.eagleus.com.

EGRX Valuation Summary

• In comparison to the median Healthcare stock, EGRX's EV/EBIT ratio is 11.45% higher, now standing at 7.3.
• Over the past 111 months, EGRX's price/sales ratio has gone down 9.

Below are key valuation metrics over time for EGRX.

EGRX Growth Metrics

Its 3 year net income to common stockholders growth rate is now at -6.3%.
• Its 2 year price growth rate is now at -21.29%.
• Its 2 year revenue growth rate is now at 28.13%.

Over the past 67 months, EGRX's revenue has gone up $61,546,000.

The table below shows EGRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	298.231	21.225	21.281
2022-06-30	272.183	35.529	22.79
2022-03-31	246.171	1.13	35.852
2021-12-31	171.546	28.219	-8.627
2021-09-30	179.142	39.898	5.626
2021-06-30	189.217	44.458	18.307

EGRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EGRX has a Quality Grade of B, ranking ahead of 92.42% of graded US stocks.
• EGRX's asset turnover comes in at 0.738 -- ranking 36th of 682 Pharmaceutical Products stocks.
• ACUR, XENE, and KMPH are the stocks whose asset turnover ratios are most correlated with EGRX.

The table below shows EGRX's key quality metrics over time.